Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
When the Price of (SAVA) Talks, People Listen | news.google.com • |
Mirae Asset Global Investments Co. Ltd. Purchases 1418 Shares of Cassava Sciences, Inc. (NASDAQ:SAVA) | news.google.com • |
SAVA June 7th Options Begin Trading | news.google.com • |
Cassava Sciences (NASDAQ:SAVA) Trading Up 4.6% | news.google.com • |
Raymond James Financial Services Advisors Inc. Decreases Holdings in Cassava Sciences, Inc. (NASDAQ:SAVA) | news.google.com • |
Cassava Sciences Announces Virtual Presentation at the AD/PD™ 2024 International Conference | globenewswire.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-06 | 2024-03 | -0.51 | N/A | N/A | N/A |
2024-02-28 | 2023-12 | -0.4 | -0.5 | -0.1 | -25.00% |
2023-11-07 | 2023-09 | -0.9 | -0.61 | 0.29 | 32.22% |
2023-08-03 | 2023-06 | -0.58 | -0.63 | -0.05 | -8.62% |
2023-05-01 | 2023-03 | -0.56 | -0.58 | -0.02 | -3.57% |
2023-02-28 | 2022-12 | -0.58 | -0.47 | 0.11 | 18.97% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-07 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-07-05 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-05-10 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-05-08 | HC Wainwright & Co. | Upgrade | Buy | |
2023-03-05 | HC Wainwright & Co. | Upgrade | Buy | |
2023-01-23 | HC Wainwright & Co. | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2018-10-02 | ARMISTICE CAPITAL L.L.C. | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Sale |
2023-05-23 | BARBIER REMI | Chief Executive Officer | 0.00 | Conversion of Exercise of derivative security |
2024-04-22 | BARRY RICHARD J | Director | 0.00 | Conversion of Exercise of derivative security |
2022-10-02 | FRIEDMANN NADAV | Officer and Director | 80.05K | Conversion of Exercise of derivative security |
2023-04-30 | GUSSIN ROBERT Z | Director | 10.62K | Conversion of Exercise of derivative security |
2024-04-17 | KUPIEC JAMES WILLIAM | Officer | 4.00K | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Blackrock Inc. | 2.75M | 67.35M | 6.54% |
2023-06-29 | Vanguard Group Inc | 2.25M | 55.16M | 5.36% |
2023-06-29 | State Street Corporation | 952.09K | 23.35M | 2.27% |
2023-06-29 | Geode Capital Management, LLC | 803.31K | 19.70M | 1.91% |
2023-06-29 | Gallacher Capital Management LLC | 583.29K | 14.30M | 1.39% |
2023-06-29 | Northern Trust Corporation | 370.64K | 9.09M | 0.88% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 1.23M | 30.21M | 2.94% |
2023-08-30 | iShares Russell 2000 ETF | 908.42K | 19.05M | 2.16% |
2023-06-29 | Vanguard Extended Market Index Fund | 542.35K | 13.30M | 1.29% |
2023-07-30 | Fidelity Small Cap Index Fund | 353.09K | 7.76M | 0.84% |
2023-08-30 | iShares Russell 2000 Growth ETF | 333.17K | 6.99M | 0.79% |
2023-05-30 | Fidelity Extended Market Index Fund | 202.34K | 4.60M | 0.48% |
Dividend | Date |
---|---|
0.75 | 2012-12-13 |
2 | 2010-12-13 |
Split | Date |
---|---|
1 : 7 | 2017-05-10 |
-
Why do I see bid ask at 75 76 lol what’s this madness
-
-
Die slow bears. Everyday all day.
-
Die slow you pieces of shit .
-
-
This is trash. Don’t invest $SAVA. $42 for today. This month is only $10. Buy put today win 100%
-
-
$SAVA weak ass clowns sell
-
$SAVA strong like bull
-
$SAVA you fuck sticks gonna fold next week. Weak ass hands. SAVA strong
-
$SAVA why you bitches selling? Bought a 1000 shares at 50
-
$SAVA love this company. I can’t wait till they release this drug to the mainstream! Hope is here!!!
-
$SAVA we live in a world where fake ass coins, tokens that were created as a joke has more market cap than a real solution Alzheimer’s. You got to ask yourself, where do you stand. With the jokes and idiots or real science and change. Sleep well my friends.
-
-
$SAVA the next pharma to change the world. My mother has Alzheimer’s so I’m buying to support! This is a miracle! Will be the next big pharma. Buy and support the cause. Phase 3 isn’t a given.
-
$SAVA seriously. Why you selling!? You scared!? Lol. Idiots. No fucks given to you if you sell now. You are missing a once in a lifetime investment. It will change medicine forever.
-
-
$SAVA think about it. You actual believe the FDA would allow phase 3 if there were actual issues? Seriously use your brain. It’s all smoke and mirrors by other drunk companies. Don’t get fooled. This will change medicine for ever. Easily a $400 equity. Hold the line.
-
$SAVA climb bitch
-
When the Price of (SAVA) Talks, People Listen
news.google.com • -
SAVA June 7th Options Begin Trading
news.google.com • -
Cassava Sciences (NASDAQ:SAVA) Trading Up 4.6%
news.google.com • -
Exit Now! 3 Biotech Stocks to Sell in February 2024
investorplace.com • -
3 small-cap biotechs with potential breakthroughs in 2024
marketbeat.com • -
3 Biotech Stocks to Sell in January Before They Crash and Burn
investorplace.com • -
Portfolio Protection: 7 Risky Stocks to Drop Right Now
investorplace.com • -
New SAVAW Warrants Are Trading After Cassava Sciences' Distribution
investorplace.com • -
Why Is Cassava Sciences (SAVA) Stock Up 15% Today?
investorplace.com • -
Why Cassava Sciences Stock Soared Today
fool.com • -
Alzheimer's Disease Drug Development: Another Lost Year
seekingalpha.com • -
7 High-Risk, High-Reward Stocks for the Extreme Contrarian
investorplace.com • -
1 Big Red Flag to Fear When a Stock Is Down
fool.com • -
Cassava Sciences: My Bullish Take On Biomarkers And CTAD Data
seekingalpha.com • -
7 Stocks That Are Heading for a Train Wreck
investorplace.com • -
SAVA Stock Continues to Plunge on Misconduct Allegations
investorplace.com • -
SAVA Stock Alert: Cassava Sciences Addresses Leaked Report
investorplace.com • -
Cassava Sciences slumps after leaked report claims 'egregious misconduct' over Alzheimer's drug
proactiveinvestors.com • -
Cassava Sciences slumps after leak claims “egregious misconduct”
proactiveinvestors.co.uk • -
Cassava Sciences to Present at the Jefferies Biotech CNS/Neuro Summit in NY
globenewswire.com • -
The 7 Best Meme Stocks to Buy Now: September 2023
investorplace.com • -
Cassava Sciences Invited to Present in Four Upcoming Investor Conferences
globenewswire.com • -
Week Of 08/28 Notable Insider Buys
seekingalpha.com • -
Week Of 08/21 Notable Insider Buys
seekingalpha.com • -
Insider Richard Barry Just Doubled Down on Cassava (SAVA) Stock
investorplace.com • -
Why These 3 Stocks Are the Worst Ways to Play Biotech Right Now
investorplace.com • -
Cassava Sciences: Positive Data Continues To Derisk Ongoing Phase 3 Trials
seekingalpha.com • -
Cassava Sciences (SAVA) Stock Drops Despite Positive Trial Results
investorplace.com • -
Cassava Sciences to Present at the Jefferies Global Healthcare Conference
globenewswire.com • -
Why Is Cassava Sciences (SAVA) Stock Up 15% Today?
investorplace.com • -
Buy Cassava Sciences For Imminent Data Readout
seekingalpha.com • -
Cassava Sciences to Present at the 2023 H.C. Wainwright Investor Conference
globenewswire.com • -
Strong Small-Cap Insider Buys: Q1 2023
seekingalpha.com • -
3 Short-Squeeze Stocks to Keep on Your Radar
investorplace.com • -
Insider Richard Barry Is Betting Big on Cassava (SAVA) Stock
investorplace.com • -
Cassava Sciences Stock Undervalued with Its $124 Price Target?
marketbeat.com • -
Cassava Sciences' Data Once Again Misunderstood
seekingalpha.com • -
Why Is Cassava Sciences (SAVA) Stock Down 20% Today?
investorplace.com • -
Is a Short Squeeze Coming in Cassava Sciences (SAVA) Stock?
investorplace.com • -
6 Favorite Biotech Bets For 2023
forbes.com • -
Why Is Cassava Sciences (SAVA) Stock Up 10% Today?
investorplace.com • -
Cassava Sciences Stock's Bull Signal Has Never Been Wrong
schaeffersresearch.com • -
7 Stocks Rattled by Corporate Scandals and Shenanigans in 2022
investorplace.com • -
Why Is Cassava Sciences (SAVA) Stock Up Today?
investorplace.com • -
Cassava Sciences Has a Big Warning for SAVA Stock Short Sellers
investorplace.com • -
Trading Ideas On The Upcoming CTAD 2022 Conference
seekingalpha.com • -
Why Is Cassava Sciences (SAVA) Stock Down 10% Today?
investorplace.com • -
SAVA Stock Alert: Cassava Sciences Extends Trial
investorplace.com • -
How High Can SAVA Stock Go Once the Controversy Clears?
investorplace.com • -
Cassava Sciences Stock: Huge Returns Or Catastrophic Losses
seekingalpha.com • -
Why Is Cassava Sciences (SAVA) Stock Heating Up Today?
investorplace.com • -
5 Investors Betting Big on Cassava (SAVA) Stock
investorplace.com • -
Cassava: High Risk Speculative Play With Enormous Potential
seekingalpha.com • -
The Huge Reason Cassava Sciences (SAVA) Stock Is Rocketing Higher
investorplace.com • -
The SEC Has Officially Cleared Cassava Sciences
seekingalpha.com • -
What Is Going on With Cassava (SAVA) Stock Today?
investorplace.com • -
Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference
globenewswire.com • -
Cassava Sciences Looks As Good Of A Purchase As Ever
seekingalpha.com • -
Insider Richard Barry Is Betting Big on Cassava (SAVA) Stock
investorplace.com • -
Why Is Cassava Sciences (SAVA) Stock Up 20% Today?
investorplace.com • -
Cassava's Simufilam And Acetylcholinesterase Inhibitors: Similar Results
seekingalpha.com • -
10 Stocks to Sell Before They Die
investorplace.com • -
Cassava (SAVA) Stock Falls 30% on Report of Criminal Probe
investorplace.com • -
7 Meme Stocks Trading at a Massive Discount Right Now
investorplace.com • -
Cassava Sciences And Alzheimer's Disease: A Precipitious Path
seekingalpha.com • -
Stay Far Away From Cassava Sciences Amid Data Integrity Criticisms
investorplace.com • -
Take Full Advantage of Weakness in Cassava Sciences Stock
investorplace.com • -
Cassava Sciences Is a Worthwhile Bet to Consider
investorplace.com • -
The Crowd Has Wisely Soured on Cassava Sciences Stock
investorplace.com • -
Fresh Crop of Concerns Surrounding Alzheimer's Drug Sinks SAVA
schaeffersresearch.com •